$RGC Huge News : Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO
-Regencell Bioscience Holdings Limited (NASDAQ: RGC) ("Regencell" or the "Company"
![](/images/icons/icon_wink.gif)
, an early-stage bioscience company focusing on the research, development and commercialization of Traditional Chinese Medicine ("TCM"
![](/images/icons/icon_wink.gif)
for the treatment of neurocognitive disorders and degenerations, as well as infectious diseases affecting people’s immune system, announced that Yat-Gai Au, the Company’s Chairman and CEO, made purchases of ordinary shares in Regencell ("Ordinary Shares"
![](/images/icons/icon_wink.gif)
totaling $5.03 million.
Based on his Schedule 13D filings with the U.S. Securities and Exchange Commission (the "SEC"
![](/images/icons/icon_wink.gif)
between July 27, 2021 and May 16, 2022, Mr. Au used an aggregate of $5.03 million of his personal funds to purchase Ordinary Shares through open market purchases. According to the latest filing, following the purchases, Mr. Au owns a total of 10,539,159 Ordinary Shares, representing 81.0% of total issued and outstanding Ordinary Shares.
https://finance.yahoo.com/news/regencell-bios...00349.html